Ozon Pharmaceuticals' net profit under IFRS for 6 months of 2025 amounted to ₽1.71 billion, which is 10.9% lower than ₽1.92 billion in the previous year. Revenue increased by 16.7% to ₽13.3 billion from ₽11.4 billion a year earlier.